Octreotide LAR in the Induction of Immunologic Response in NENs Patients
Clinical trial NCT04129255 · COMPLETED
Trial details
- NCT number
- NCT04129255
- Sponsor
- National Cancer Institute, Naples
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-28
- Primary completion
- 2019-12-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.